Niederst, M. J., Hu, H., Mulvey, H. E., Lockerman, E. L., Garcia, A. R., Piotrowska, Z., . . . Engelman, J. A. (2015). The allelic context of the C797S mutation acquired upon treatment with third generation EGFR inhibitors impacts sensitivity to subsequent treatment strategies. Clin Cancer Res.

Niederst, Matthew J., Haichuan Hu, Hillary E. Mulvey, Elizabeth L. Lockerman, Angel R. Garcia, Zofia Piotrowska, Lecia V. Sequist, and Jeffrey A. Engelman. "The Allelic Context of the C797S Mutation Acquired Upon Treatment With Third Generation EGFR Inhibitors Impacts Sensitivity to Subsequent Treatment Strategies." Clin Cancer Res 2015.

Niederst, Matthew J., et al. "The Allelic Context of the C797S Mutation Acquired Upon Treatment With Third Generation EGFR Inhibitors Impacts Sensitivity to Subsequent Treatment Strategies." Clin Cancer Res 2015.